Invest in Zoetis Now and Take Advantage of Its Diversified Revenue Streams and Favorable Valuation
January 16, 2023
Trending News ☀️
Zoetis Inc Stock Fair Value – Zoetis Inc ($NYSE:ZTS). is a leader in the animal health industry, specializing in treatments and diagnostics for a variety of animals such as livestock, pets and more. Zoetis’ diversified revenue streams make it an attractive investment opportunity. With a wide range of products and services, investors can benefit from the company’s expertise in the animal health market. Zoetis offers a comprehensive portfolio of products for livestock, companion animals and horses, including pharmaceuticals, vaccines, diagnostics, parasiticides, nutritionals, genetics and reproductive products.
The company also provides services, such as veterinary practices and supply chain management. Zoetis’ diversified revenue sources create multiple opportunities for investors to benefit from its offerings. In addition to its diversified revenue streams, the current valuation of Zoetis is favorable for potential investors. Overall, now is an opportune moment to invest in or up your position in Zoetis.
Share Price
Investing in Zoetis Inc now could be a wise decision for investors. At the time of writing, media sentiment is mostly positive and on Tuesday, the stock opened at $147.1 and closed at $154.4, up 5.0% from its last closing price of $147.1. Zoetis Inc offers a diversified revenue stream that is attractive to investors. Its product portfolio includes a range of animal health products and services that address the important health needs of both companion and farm animals. This includes vaccines, pharmaceuticals, diagnostic products and services, genetic tests, feed additives, and other products. This gives them a competitive edge over other companies in the sector.
Moreover, the company’s financial performance has been strong, with revenues increasing at a steady rate over the past few years. This suggests that the stock is undervalued compared to its peers and could provide investors with an attractive entry point into the sector. Overall, Zoetis Inc offers a compelling case for investing now. Its diversified revenue stream, strong presence in the global animal health market, and favorable valuation make it an attractive opportunity for investors. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Zoetis Inc. More…
| Total Revenues | Net Income | Net Margin |
| 8.01k | 2.07k | 26.7% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Zoetis Inc. More…
| Operations | Investing | Financing |
| 1.85k | -587 | -2k |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Zoetis Inc. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 13.67k | 9.01k | 10 |
Key Ratios Snapshot
Some of the financial key ratios for Zoetis Inc are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 9.2% | 13.2% | 34.8% |
| FCF Margin | ROE | ROA |
| 15.8% | 37.6% | 12.7% |
VI Analysis – Zoetis Inc Stock Fair Value
ZOETIS INC, a company whose fundamentals reflect its long term potential, is a great opportunity for investors. According to the VI Line, the fair value of the company’s share is estimated to be around $186.7, whereas the current price of the share is traded at $154.4, which is 17% undervalued. This presents investors with an opportunity to invest in a company that has strong fundamentals and a good long-term outlook. Moreover, the company has engaged in share buybacks, which indicates that the company believes in its own stock and is confident in its long term prospects. Overall, ZOETIS INC presents investors with an attractive opportunity due to its strong fundamentals and attractive valuations. The company has strong financials, healthy margins, consistent revenue growth, and generous dividend yield, which make it an ideal investment for those looking for long term returns. More…
VI Peers
Zoetis Inc. is a global animal health company that develops, manufactures, and markets a wide range of veterinary products. The company’s products include vaccines, parasiticides, pharmaceuticals, diagnostics, and biologics. Zoetis Inc. has a broad portfolio of products that are used in the prevention, treatment, and control of disease in animals. The company’s competitors include BioGaia AB, Krka d.d., and Phibro Animal Health Corp.
– BioGaia AB ($OTCPK:BIOGY)
Biogaia is a Swedish biotech company that markets probiotic products for infants, children, and adults. The company’s products are based on the lactic acid bacterium Lactobacillus reuteri, which is found naturally in the human gastrointestinal tract. Biogaia’s products are sold in over 60 countries worldwide.
Biogaia’s market cap is 800.05M as of 2022. The company has a Return on Equity of 10.86%. Biogaia’s products are based on the lactic acid bacterium Lactobacillus reuteri, which is found naturally in the human gastrointestinal tract. Biogaia’s products are sold in over 60 countries worldwide.
– Krka d.d. ($LTS:0HLK)
Krka d.d. is a Slovenian pharmaceutical company. It is the largest pharmaceutical company in Slovenia and one of the largest in the Balkans. The company was founded in 1959 and is headquartered in Novo mesto. Krka d.d. has a market cap of 2.77B as of 2022 and a Return on Equity of 12.85%. The company’s main products are prescription drugs, over-the-counter drugs, and medical devices.
– Phibro Animal Health Corp ($NASDAQ:PAHC)
Phibro Animal Health Corporation is a diversified animal health and specialty ingredients company with products in over 100 countries. The company’s products are sold through veterinarians, distributors, and feed stores. Phibro Animal Health Corporation’s mission is to improve the health and productivity of animals. The company’s products are used in a variety of animals, including cattle, swine, poultry, and aquaculture. Phibro Animal Health Corporation’s products are designed to improve the health and productivity of animals while providing a safe and healthy environment for them to live in.
Summary
Zoetis Inc is an attractive investment opportunity for investors looking for growth and value. The company has a diversified revenue stream, with products and services in the animal health, diagnostics, and biopharmaceutical industries, which provides a strong foundation for long-term growth.
Additionally, favorable valuations make it an even more appealing choice in the current market. Media sentiment is mostly positive, which is reflected in the stock price that has been steadily increasing since the beginning of the year. Investment in Zoetis Inc could be a smart choice for investors seeking to capitalize on its potential.
